Sanofiadds another first in the OTC intranasal corticosteroid market it pioneered with Nasacort Allergy 24HR by launchingthe first product in the class that FDA approved to include “children’s” on its packaging.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?